key: cord-0820615-jhhevshw
authors: Banholzer, N.; Lison, A.; Ozcelik, D.; Stadler, T.; Feuerriegel, S.; Vach, W.
title: The methodologies to assess the effects of non-pharmaceutical interventions during COVID-19: a systematic review
date: 2022-04-18
journal: nan
DOI: 10.1101/2022.04.14.22273858
sha: f3f681ea8ada97b211524ce4a25d3340e2ea8a94
doc_id: 820615
cord_uid: jhhevshw

Non-pharmaceutical interventions, such as school closures and stay-at-home orders, have been implemented around the world to control the spread of SARS-CoV-2. Their effects on health-related outcomes have been the subject of numerous empirical studies. However, these studies show fairly large variation among methodologies in use, reflecting the absence of an established methodological framework. On the one hand, variation in methodologies may be desirable to assess the robustness of results; on the other hand, a lack of common standards can impede comparability among studies. To establish a comprehensive overview over the methodologies in use, we conducted a systematic review of studies assessing the effects of non-pharmaceutical interventions on health-related outcomes between January 1, 2020 and January 12, 2021 (n=248). We identified substantial variation in methodologies with respect to study setting, outcome, intervention, methodological approach, and effect assessment. On this basis, we point to shortcomings of existing studies and make recommendations for the design of future studies.

Studies assessed for eligibility (n = 411)

Studies not retrieved (n = 0)

Studies excluded § Only simulation of NPI effects in hypothetical scenarios (n = 105) § Different research objective than assessment of NPI effects (n = 30) § Only assessment of effects of mobility or behavior, not of NPIs (n = 17) § Use of results from other study (n = 6) § Extraction not feasible due to quality issues (n = 4) § Not available in English language (n = 1)

Overall, n=248 studies were included. Some studies contain multiple analyses, such that the number of analyses included in the review is 285. 88 The analyses vary in their scope across populations, geographic areas, and study period. A systematic 89 classification of the study setting is shown in Table 1 . More than half of the analyses studied multiple populations (n=167; 59 %), i. e. multiple countries 92 or subnational regions (e. g. states or cities). The remainder focused on a single population (n=118; 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint Almost all raw data were obtained at daily resolution (n=269; 94 %). Exceptions were data on 156 surrogate diseases or from surveys, where reporting was usually only broken down in weekly, biweekly, 157 or monthly intervals (n=16; 6 %).

Computed outcome 159 Around half of the analyses involved an intermediate step, in which a latent outcome was computed 160 from the raw data before assessing the effects of interventions. We identified four main types of 

Of note, the raw outcome was not always used only for obtaining the computed outcome, e. g. Method to obtain the computed outcome 179 1) Measures of epidemic trend were often obtained through simple computation (e. g. growth rate 180 as percentage change in confirmed cases). Other analyses used simple modeling approaches, 181 9/46 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Data source 199 The majority of authors directly accessed surveillance data from national health authorities or other 200 governmental bodies (n=141; 49 %). In the case of individual-level data, which may be subject 201 to privacy regulations, authors were often themselves affiliated to the relevant health authority.

To obtain population-level data, a considerable share of analyses also used publicly available data 203 from cross-country selections (n=77; 27 %), e. g. the European Centre for Disease Prevention and 204 Control (ECDC) 29 , the Johns Hopkins University (JHU) 30 , or Worldometer 31 , which offer aggregated 205 surveillance data internationally from various sources for the pandemic. Mobile phone tracking 206 data were usually provided by corporate organizations (n=40; 14 %) such as Google 32 , Apple 33 , or 207 Baidu 34 . A few analyses were also based on data collected by the authors, e. g. survey data on 208 behavioral outcomes, seroprevalence studies, or data collected at a local facility such as a hospital.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint level outcomes such as cases and deaths because such data could oftentimes be accessed via the 212 source that is documented in the manuscript (n=173; 61 %). In several cases, the data was made 213 publicly available by the study authors (n=76; 27 %), e. g. by depositing the analyzed data in a 214 public repository. For a small, yet considerable number of analyses, data was not accessible (n=36; 215 13 %) as the data was neither made publicly available nor the source of the data could be identified.

Of note, data on epidemiological individual-level data was typically not available due to privacy 217 concerns. Furthermore, corporate mobility data was widely available in the past, but access has 218 recently been restricted by many providers. Table 3 . 223 Varying terminology was used by the literature to refer to non-pharmaceutical interventions. This is 224 reflected in our search string, where we used a large set of terms in order to capture a broad range of 225 relevant studies. One part of our search string considers the different terminology for interventions 226 in general, while the other part considers the terminology for the specific type of non-pharmaceutical 227 interventions. In our review, the most frequent terms for interventions were "measures" (n=135; 228 54 %), followed by "interventions" (n=65; 26 %) and "policies" (n=16; 6 %). The most frequent 229 terms for the specific type of non-pharmaceutical interventions were "non-pharmaceutical" (n=49; 230 16 %), "control" (n=48; 16 %), and "social distancing" (n=45; 15 %). While terminology sometimes 231 reflected the specific types of non-pharmaceutical interventions that were analyzed, differences in 232 terminology may also be the result of different research backgrounds of the study authors. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 18, 2022. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint A considerable number of analyses examined one single (n=43; 15 %) 5, 35 or multiple interventions 235 separately (n=31; 11 %) 2, 7 . Among these analyses, the effects of school closures (n=25; 34 %) 236 and stay-at-home orders (n=44; 59 %) were assessed most frequently, which may be due to these 237 interventions being particularly controversial in the public discourse 36, 37 . The majority of analyses, 238 however, did not analyze the separate effects of multiple interventions but rather analyzed the joint 239 effect for a combination of multiple interventions (n=84; 29 %) 38-40 , which is often the case when 

Of note, analyses that assessed the effects of a combination of interventions often referred to this 249 combination as "lockdown". In the underlying analysis, such lockdowns typically included multiple 250 interventions implemented on the same day 39, 50 . However, the specific interventions included in 251 lockdowns varied considerably between populations. We therefore considered "lockdown" as an 252 umbrella term for different combinations of interventions rather than as a specific type of intervention.

Furthermore, some studies did not only assess the effects of non-pharmaceutical interventions on 254 mobility, but also the effects of changes in mobility on population-level epidemiological outcomes.

In these analyses, human mobility was typically defined as a continuous exposure. We extracted 256 information on such complementary analyses of mobility as an addendum to the main review (see SI 257 Appendix E). 259 When multiple populations were jointly analyzed, coding of interventions may have been necessary 260 in order to reconcile differences in the definitions of interventions between populations. For instance, 261 the term "school closures" could refer to the closure of primary or secondary schools or universities.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint intervention and providing a common name and definition that is then applied to all populations.

Such coding of interventions was necessary in around a quarter of analyses (n=74; 26 %). 266 If coding of interventions was not necessary, authors often obtained intervention data (i. e. the date 267 of interventions) from a government or news website (n=30; 22 %). Unfortunately however, the data 268 source was often not provided by the authors and could thus not be evaluated (n=98; 72 %). If 269 coding of interventions was necessary, then study authors either coded the data themselves (n=20; Table 4 .

Empirical approach 284 We distinguished three general empirical approaches for assessing the effects of interventions, namely . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 18, 2022. ; Table 4 . Systematic classification and frequency of the methodological approach (D.4).

Total freq. (v) mechanistic model, and (vi) synthetic controls. We review these in the following. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint models were fitted using data prior to when an intervention was implemented and then extrapolated 356 the outcome afterwards.

(v) Mechanistic model 358 Mechanistic models have a structure that makes, to some extent, explicit assumptions about the 359 mechanisms that drive infection dynamics. They were used in both parametric and counterfactual 360 approaches (n=43; 15 %).

In parametric approaches, the effect of an intervention was represented via a parameter that In counterfactual approaches, mechanistic models were, similar to non-mechanistic models, 384

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint the time after the intervention, while keeping the model parameters fixed 85-87 . Thus, no relationship 386 between intervention and outcome is explicitly modeled. Regularly, these analyses used meta-387 population or individual-based models that incorporated migration dynamics through mobility data Code availability 398 For around one in four analyses, a link to a publicly accessible repository containing the computer 399 code implemented for a specific analysis was provided (n=65; 23 %). Overall, the code availability 400 was comparably higher for parametric approaches, where one in three analyses provided a link. 402 The analyses in our review sample varied in their form of effect assessment, i. e. how the effect 403 was quantified, whether uncertainty was reported, and whether sensitivity analyses or subgroup 404 assessments were conducted. A systematic classification of the effect assessment is shown in Table 5 . 406 The are difference in how effects of interventions were reported. Around one in five analyses made 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint Table 5 . Systematic classification and frequency of different effect assessments (D.5).

Total freq. 

None (no sensitivity analyses w.r.t effect) 217 (76 %) One ore more sensitivity analyses one or more sensitivity analyses is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint Box 1. Different types of analyses to assess the effects of non-pharmaceutical interventions.

(1) Observed outcome directly linked to interventions A raw, observed outcome is analyzed directly by evaluating differences (i) over time with an interrupted time-series analysis comparing the outcome before vs. after an intervention, (ii) between populations with a cross-sectional analysis comparing populations exposed vs. not exposed to an intervention, or (iii) both over time and between populations with a panel data analysis. Mechanistic modeling is typically not involved in this type of analysis, with one exception, namely counterfactual approaches using a transmission model to project the observed outcome after intervention.

(2) Computed, unobserved outcome linked to interventions In contrast to type (1), the intervention effect is measured in terms of an unobserved outcome. This is computed from the raw outcome and then analyzed in a similar manner as in (1) . Mechanistic modeling can be involved in computing the unobserved outcome, for example by using a model to estimate the reproduction number or transmission rate from the number of new cases.

Observed outcomes are used to fit a mechanistic model (e. g. compartmental transmission model) that includes a latent variable representing an unobserved outcome (e. g. the reproduction number), which in turn is parameterized as a function of interventions. For instance, a regression-like link is used within the mechanistic model to estimate the effect of interventions on the transmission rate as a latent variable. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint mechanistic modeling by directly analyzing an observed outcome such as cases or deaths. Here, a 521 central challenge is to take into account the uncertain delay between the implementation of non-522 pharmaceutical interventions and their effects on the observable outcome. The fact that infections 523 and subsequent outcomes such as confirmed cases follow exponential dynamics during an epidemic 524 wave makes it difficult to compare intervention effects measured by observable outcomes across 525 different epidemic phases. In contrast to that, analyses following type (2) or (3) employ mechanistic 526 modeling, allowing to assess the effects of interventions on latent, unobservable outcomes such as 527 the transmission rate or the reproduction number. Since these latent outcomes can be inferred from 528 different observed outcomes like cases or deaths, it becomes possible to compare analyses that use 529 different raw data. The difference between type (2) and (3) is that for (2) the estimation of the latent 530 outcome is separated from the effect assessment. Such separation reduces model complexity, however, 531 often at the expense of incomplete uncertainty assessments. The reason is that most analyses based 532 on type (2) only incorporated uncertainty involved in modeling the effect of interventions on the 533 latent outcome, thus leaving out uncertainty involved in the computation of the latent outcome.

This also means that differences in uncertainty assessments must be carefully taken into account 535 when synthesizing results from multiple studies. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint of the same population (e. g. between the young and elderly population); and (ii) comparing the 549 effects of interventions between different populations and relating differences to population-specific 550 characteristics (e. g. population density). other aspects, in particular the specific setting and methodologies used, are presumably more difficult 562 to vary as part of a sensitivity analysis, and may therefore need to be compared between different 563 studies. Important for such comparisons is giving access to the preprocessed data, yet most study 564 authors accessed these data directly from national authorities or external data providers without 565 making the preprocessed data additionally available ( To promote reproducibility, study authors should always make the preprocessed data available for 567 two reasons. First, future access to the data via the original source may be restricted (this has 568 already been observed for corporate mobility data). Second, originally analyzed and recently accessed 569 data may be different as publicly available epidemiological data and coded intervention data can be 570 subject to updates, revisions, and corrections. In addition, publication of computed code is crucial 571 to support comparisons of methodological approaches, specific modeling choices, and input data. During the COVID-19 pandemic, a tremendous amount of publicly available epidemiological 595 data has been generated. The ease of access to this data allowed many researchers to contribute 596 work, using a variety of methodologies to assess the effects of non-pharmaceutical interventions 597 on health-related outcomes. With researchers from diverse fields contributing, there is a unique 598 opportunity to benefit from the various inputs in developing a methodological foundation for timely 599 and robust assessments during future pandemics. This will however require a thorough examination 600 of the present methodologies in order to share lessons learnt and develop best practices. Our 601 systematic review can be viewed as a first such attempt. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint

We tailored our review to the challenge of mapping a potentially diverse set methodologies from 604 a large number of studies. To ensure rigour and consistency, we preregistered the procedures for 605 all stages of the review process, following common guidelines for systematic literature reviews 17 .

Certain guidelines were not applicable to a methodology review as ours. In particular, our eligibility 607 criteria and risk of bias assessment reflect the objective of this review, which was not to evaluate the 608 effects of non-pharmaceutical interventions, but to map the variation in methodologies used. The 609 preregistered methodology was documented in a review protocol at PROSPERO 19 . 610 We report our review according to the PRISMA 2020 statement 18 . A completed PRISMA 2020 611 checklist is provided in SI Appendix G. We conceptualized the review by drawing on experience from 612 our own primary research in the field 4, 97 . The search strategy was developed jointly and executed by 613 an experienced information consultant. Then, two authors (NB and AL) performed study selection, 614 data extraction, and synthesis, while having regular meetings with the complete author team. 616 In the following, we describe our eligibility criteria, which informed our search strategy and were 617 systematically applied during study selection. Importantly, if a study contained multiple analyses of 618 which only some fulfilled our eligibility criteria, we included the study but extracted only the eligible 619 analyses. This may sometimes not correspond to the main analysis of a paper or may include more 620 than one analysis per study. 622 In this review, we considered observational studies assessing the effects of non-pharmaceutical 623 interventions on outcomes related to the COVID-19 disease. We focused on retrospective analyses 624 that used real-world observational data to assess the effects of non-pharmaceutical interventions. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint one or several geographic regions. Our review was not limited to a specific geographic region, i. e. 631 all national and subnational regions worldwide were considered. We furthermore included studies 632 analyzing specific subpopulations in a certain region (e. g. certain age groups). We also considered 633 analyses using individual-level data, as long as the intervention effect was assessed on a population 634 level.

Outcome 636 The main outcomes considered were health-related outcomes at population level that are associated 637 with COVID-19 (e. g. confirmed cases, hospitalizations, and deaths), and epidemiological outcomes 638 characterizing infection dynamics such as reproduction numbers or transmission rates. We also 639 considered similar outcomes associated with other infectious diseases (e. g. influenza), if used as 640 a surrogate for COVID-19. Moreover, behavioral outcomes potentially mediating the effect of 641 non-pharmaceutical interventions were included (e. g. human mobility). In contrast, we excluded 642 analyses assessing the effects of non-pharmaceutical interventions solely on other outcomes not 643 directly related to infectious diseases (e. g. psychological well-being or economic activities). 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint primary research on the impact of non-pharmaceutical interventions. The search was supported by 659 an experienced information consultant. 660 We searched for peer-reviewed original research articles in English language that were accepted, 661 published, or in press between January 1, 2020 and January 12, 2021. In our review protocol, 662 we specified that we would also include preprints in our search. However, due to their enormous 663 volume, we eventually decided not to consider gray literature or preprints in our review. Our results 664 therefore only cover methodologies used by articles peer-reviewed at the time of search, among 665 which we already found considerable variation. To account for potentially new methodologies in 666 articles published after the time of search, we also considered further recent studies on the effects 667 of non-pharmaceutical interventions in our discussion and put them into the context of our review 668 findings. 669 We searched the databases Embase, PubMed, Scopus, and Web of Science. These databases 670 include, among others, MEDLINE, Biological Abstracts, CAB Abstracts, and Global Health. We 671 composed our search query of four components to be contained in the publication title or abstract:

(1) a synonym for "non-pharmaceutical intervention", (2) a synonym for "estimation" or "assessment",

(3) a synonym for "effect", and (4) a synonym for "COVID-19". Starting from a precompiled list 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint As a first step, we screened the titles of the studies retrieved from the database search for keywords 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint vealing Fine-Scale Spatiotemporal Differences in SARS-CoV-2 Introduction and Spread. Nature 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273858 doi: medRxiv preprint

A Global Panel 744 Database of Pandemic Policies (Oxford COVID-19 Government Response Tracker)

Inferring the 747

Effectiveness of Government Interventions against COVID-19

Ranking the 749 Effectiveness of Worldwide COVID-19 Government Interventions

Estimating the 752 Effects of Non-Pharmaceutical Interventions on the Number of New Infections with COVID-19 753 during the First Epidemic Wave

Association 755 between Statewide School Closure and COVID-19 Incidence and Mortality in the US

All Things Equal? Heterogeneity in Policy Effectiveness against COVID-19 Spread 758 in Chile

Strong Social Distancing Measures 760 in the United States Reduced the COVID-19 Growth Rate

How Do Non-Pharmaceutical Interventions Affect the Spread of 772 COVID-19? A Literature Review

Pharmaceutical Interventions Related to Social Distancing on Respiratory Viral Infectious Disease 775 Outcomes: A Rapid Evidence-Based Review and Meta-Analysis

Effec-777 tiveness of Non-Pharmaceutical Public Health Interventions against COVID-19: A Systematic 778 Review and Meta-Analysis

Measures in Reducing the Incidence of COVID-19, SARS-CoV-2 Transmission, and Covid-19

Mortality: Systematic Review and Meta-Analysis

Non-Pharmaceutical Interventions during the COVID-19 Pandemic: A Review

Cochrane Handbook for 785 Systematic Reviews of Interventions

The PRISMA 787 2020 Statement: An Updated Guideline for Reporting Systematic Reviews

A Comparison of Studies Estimating the 789

Evolution 792 and Epidemic Spread of SARS-CoV-2 in Brazil

Competing interests